Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 9/20 | 0.79 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.79 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.79 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | HPGD | P15428 | 2/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.79 |
| ▸ | RARB | P10826 | 1/20 | 0.79 |
| ▸ | RARG | P13631 | 1/20 | 0.79 |
| ▸ | DRD1 | P21728 | 1/20 | 0.79 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.79 |
| ▸ | PGR | P06401 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11743186 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11787193 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11747539 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL2954691 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL29356252 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL2954688 | 1.00 | PTGIR (0.79) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11865139 | 0.99 | PTGIR (0.77) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11865151 | 0.99 | PTGIR (0.77) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11865144 | 0.99 | PTGIR (0.77) | PTGIRPTGER2PTGER4TSHRABCC4 | |
| SCHEMBL11787423 | 0.94 | PTGIR (0.69) | PTGIRPTGER2PTGER4TSHRABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220023219-A1 | Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof | XI'AN HANFENG PHARMACEUTICAL CO., LTD. (CN) | 2022-01-27 | — | — | US | disclosed |
| EP-3888637-A1 | LYOPHILIZED PREPARATION FOR PROSTAGLANDIN E1 METHYL ESTER INJECTION, PREPARATION THEREOF AND APPLICATION THEREOF | Xi'an Libang Zhaoxin Biotechnology Co., Ltd. (CN) | 2021-10-06 | — | — | EP | disclosed |
| EP-2928501-B1 | CARRIER-LINKED PROSTANOID PRODRUGS | ASCENDIS PHARMA AS (DK) | 2020-05-06 | — | — | EP | disclosed |
| US-9913912-B2 | Carrier-linked prostanoid prodrugs | ASCENDIS PHARMA A/S (DE) | 2018-03-13 | — | — | US | disclosed |
| EP-2579866-B1 | INTRAVAGINAL ADMINISTRATION OF MISOPROSTOL | FERRING BV (NL) | 2016-05-18 | — | — | EP | disclosed |
| WO-2014086961-A1 | CARRIER-LINKED PROSTANOID PRODRUGS | ASCENDIS PHARMA A/S (DK) | 2014-06-12 | — | — | WO | disclosed |
| US-20130197081-A1 | INTRAVAGINAL ADMINISTRATION OF MISOPROSTOL | FERRING B.V. (NL) | 2013-08-01 | — | — | US | disclosed |
| US-7772278-B2 | Nitrosated and nitrosylated prostaglandins, compositions and methods of use | NITROMED, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| US-20090088366-A1 | NITROSATED AND NITROSYLATED PROSTAGLANDINS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2009-04-02 | — | — | US | disclosed |
| US-7449595-B2 | for treating or preventing sexual dysfunctions in males and females, for enhancing sexual responses in males and females, and for treating or preventing cerebrovascular disorders, cardiovascular disorders, benign prostatic hyperplasia (BPH), glaucoma, peptic ulcers or for inducing abortions | NITROMED, INC. (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070112067-A1 | Nitrosated and nitrosylated prostaglandins, compositions and methods of use | NITROMED, INC. (US) | 2007-05-17 | — | — | US | disclosed |
| US-7176238-B1 | Nitrostated and nitrosylated prostaglandins, compositions and methods of use | NITROMED INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-3970683-A | 11,15-Dihydroxy-9-oxoprost-13-ynoic acid | G. D. SEARLE & CO. (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023219-A1 | Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof | PTGER1, PTGIS, PTGES | PTGIR 5/4885PTGER2 9/4885PTGER4 8/4885 |
| US-20090088366-A1 | NITROSATED AND NITROSYLATED PROSTAGLANDINS, COMPOSITIONS AND METHODS OF USE | PTGIS, PGF, PTGS1 | PTGIR 9/4885PTGER2 17/4885PTGER4 16/4885 |
| US-20070112067-A1 | Nitrosated and nitrosylated prostaglandins, compositions and methods of use | PTGIS, PGF, PTGS1 | PTGIR 9/4885PTGER2 17/4885PTGER4 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.